Skip to main content
SpringerLink
Log in

Stem Cell Transplantation for Hematologic Malignancies

  • Chapter
Hematopoietic Stem Cell Transplantation

Part of the book series: Contemporary Hematology ((CH))

  • 1418 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Horton R, Wilming L, Rand V, et al. Gene map of the extended human MHC. (Review). Nat Rev Genet 2004; 5:889–899.

    PubMed  CAS  Google Scholar 

  2. Marsh SG. Nomenclature for factors of the HLA System, update December 2004. Hum Immunol 2005; 66:329–330.

    PubMed  CAS  Google Scholar 

  3. Begovich AB, McClure GR, Suraj VC, et al. Polymorphism, recombination, and linkage disequilibrium within the HLA class II region. J Immunol 1992; 148:249–258.

    PubMed  CAS  Google Scholar 

  4. Parham P, Lomen CE, Lawlor DA, et al. Nature of polymorphism in HLA-A, -B, and -C molecules. Proc Natl Acad Sci USA 1988; 85:4005–4009.

    PubMed  CAS  Google Scholar 

  5. Mori M, Beatty PG, Graves M, Boucher KM, Milford EL. HLA gene and haplo-type frequencies in the North American population: the National Marrow Donor Program Donor Registry. Transplantation 1997; 64:1017–1027.

    PubMed  CAS  Google Scholar 

  6. Lonjou C, Clayton J, Cambon-Thomsen A, Raffoux C. HLA -A, -B, -DR haplo-type frequencies in France—implications for recruitment of potential bone marrow donors. Transplantation 1995; 60:375–383.

    PubMed  CAS  Google Scholar 

  7. Schipper RF, D'Amaro J, Bakker JT, Bakker J, van Rood JJ, Oudshoorn M. HLA gene haplotype frequencies in bone marrow donors worldwide registries. Hum Immunol 1997; 52:54–71.

    PubMed  CAS  Google Scholar 

  8. Tiercy JM, Bujan-Lose M, Chapuis B, et al. Bone marrow transplantation with unrelated donors: what is the probability of identifying an HLA-A/B/Cw/DRB1/ B3/B5/DQB1-matched donor? Bone Marrow Transplant 2000; 26:437–441.

    PubMed  CAS  Google Scholar 

  9. Kempenich JH, Setterholm M, Maiers M. Haplotype associations of 90 rare alleles from the National Marrow Donor Program. Tissue Antigens 2006; 67:284–289.

    PubMed  CAS  Google Scholar 

  10. Price P, Witt C, Allcock R, et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases (Review). Immunol Rev 1999; 167:257–274.

    PubMed  CAS  Google Scholar 

  11. Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Molecular Biology and Evolution 1995; 12:921–927.

    PubMed  CAS  Google Scholar 

  12. Kollman C, Abella E, Baitty RL, et al. Assessment of optimal size and composition of the U.S. National Registry of hematopoietic stem cell donors. Transplantation 2004; 78:89–95.

    PubMed  Google Scholar 

  13. Schreuder GM, Hurley CK, Marsh SG, et al. The HLA Dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5 and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Eur J Immunogenet 2001; 28:565–596.

    PubMed  CAS  Google Scholar 

  14. Hurley CK, Baxter-Lowe LA, Begovich AB, et al. The extent of HLA class II allele level disparity in unrelated bone marrow transplantation: analysis of 1259 National Marrow Donor Program donor-recipient pairs. Bone Marrow Transplant 2000; 25:385–393.

    PubMed  CAS  Google Scholar 

  15. Scott I, O'Shea J, Bunce M, et al. Molecular typing shows a high level of HLA class I incompatibility in serologically well matched donor/patient pairs: implications for unrelated bone marrow donor selection. Blood 1998; 92:4864–4871.

    PubMed  CAS  Google Scholar 

  16. Sasazuki T, Juji T, Morishima Y, et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. N Engl J Med 1998; 339:1177–1185.

    PubMed  CAS  Google Scholar 

  17. Morishima Y, Sasazuki T, Inoko H, et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood 2002; 99:4200–4206.

    PubMed  CAS  Google Scholar 

  18. Petersdorf EW, Gooley TA, Anasetti C, et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood 1998; 92:3515–3520.

    PubMed  CAS  Google Scholar 

  19. Flomenberg N, Baxter-Lowe LA, Confer D, et al. Impact of HLA class I and class II high resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplant outcome. Blood 2004; 104:1923–1930.

    PubMed  CAS  Google Scholar 

  20. Petersdorf EW, Hansen JA, Martin PJ, et al. Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. N Engl J Med 2001; 345:1794–1800.

    PubMed  CAS  Google Scholar 

  21. Petersdorf EW, Anasetti C, Martin PJ, et al. Limits of HLA mismatching in unrelated hematopoietic cell transplantation. Blood 2004; 104:2976–2980.

    PubMed  CAS  Google Scholar 

  22. Anasetti C, Hansen JA. Effect of HLA incompatibility in marrow transplantation from unrelated and HLA-mismatched related donors. Transfus Sci 1994; 15:221–230.

    PubMed  CAS  Google Scholar 

  23. Karre K, Ljunggren HG, Piontek G, Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986; 319:675–678.

    PubMed  CAS  Google Scholar 

  24. Parham P. MHC class I molecules and KIRs in human history, health and survival (Review). Nature Reviews Immunology 2005; 5:201–214.

    PubMed  CAS  Google Scholar 

  25. Marsh SG, Parham P, Dupont B, et al. Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Immunogenetics 2003; 55:220–226.

    PubMed  Google Scholar 

  26. Hsu KC, Chida S, Geraghty DE, Dupont B. The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism (Review). Immunol Rev 2002; 190:40–52.

    PubMed  CAS  Google Scholar 

  27. Witt CS, Dewing C, Sayer DC, Uhrberg M, Parham P, Christiansen FT. Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence for recombination. Transplantation 1999; 68:1784– 1789.

    PubMed  CAS  Google Scholar 

  28. Toneva M, Lepage V, Lafay G, et al. Genomic diversity of natural killer cell receptor genes in three populations. Tissue Antigens 2001; 57:358–362.

    PubMed  CAS  Google Scholar 

  29. Valiante NM, Uhrberg M, Shilling HG, et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997; 7:739–751.

    PubMed  CAS  Google Scholar 

  30. Norman PJ, Carrington CV, Byng M, et al. Natural killer cell immunoglobulin-like receptor (KIR) locus profiles in African and South Asian populations. Genes & Immunity 2002; 3:86–95.

    CAS  Google Scholar 

  31. Denis L, Sivula J, Gourraud PA, et al. Genetic diversity of KIR natural killer cell markers in populations from France, Guadeloupe, Finland, Senegal and Reunion. Tissue Antigens 2005; 66:267–276.

    PubMed  CAS  Google Scholar 

  32. Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295:2097– 2100.

    PubMed  CAS  Google Scholar 

  33. Aversa F, Tabilio A, Velardi A, et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 1998; 339:1186–1193.

    PubMed  CAS  Google Scholar 

  34. Petersdorf EW, Kollman C, Hurley CK, et al. Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program experience. Blood 2001; 98:2922–2929.

    PubMed  CAS  Google Scholar 

  35. Petersdorf EW, Longton GM, Anasetti C, et al. Definition of HLA-DQ as a transplantation antigen. PNAS 1996; 93:15358ȃ15363.

    PubMed  CAS  Google Scholar 

  36. Heemskerk MB, van Walraven SM, Cornelissen JJ, et al. How to improve the search for an unrelated haematopoietic stem cell donor. Faster is better than more! Bone Marrow Transplant 2005; 35:645–652.

    CAS  Google Scholar 

  37. Ringden O, Schaffer M, Le Blanc K, et al. Which donor should be chosen for hemat-opoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomi-cally identical volunteers? Biol Blood Marrow Transplant 2004; 10:128–134.

    PubMed  Google Scholar 

  38. O'Donnell PV, Luznik L, Jones RJ, et al. Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplanta-tion cyclophosphamide. Biol Blood Marrow Transplant 2002; 8:377–386.

    PubMed  Google Scholar 

  39. O'Reilly RJ, Keever C, Kernan NA, et al. HLA nonidentical T cell depleted marrow transplants: a comparison of results in patients treated for leukemia and severe combined immunodeficiency disease. Transplant Proc 1987; 19:55–60.

    PubMed  Google Scholar 

  40. Soiffer RJ, Mauch P, Fairclough D, et al. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors. Biol Blood and Marrow Transplantation 1997; 3:11–17.

    CAS  Google Scholar 

  41. Keever-Taylor CA, Bredeson C, Loberiza FR, et al. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion. Biol Blood Marrow Transplant 2001; 7:620–630.

    PubMed  CAS  Google Scholar 

  42. Henslee-Downey PJ, Parrish RS, Macdonald JS, et al. Combined in vitro and in vivo T lymphocyte depletion for the control of graft-versus-host disease following haploidentical marrow transplant. Transplantation 1996; 61:738–745.

    PubMed  CAS  Google Scholar 

  43. Kernan NA, Flomenberg N, Dupont B, O'Reilly RJ. Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic T lymphocytes. Transplantation 1987; 43:842–847.

    PubMed  CAS  Google Scholar 

  44. Beatty PG, Clift RA, Mickelson EM, et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 1985; 313:765–771.

    PubMed  CAS  Google Scholar 

  45. Beelen DW, Ottinger HD, Elmaagacli A, et al. Transplantation of filgrastim-mobilized peripheral blood stem cells from HLA-identical sibling or alternative family donors in patients with hematologic malignancies: a prospective comparison on clinical outcome, immune reconstitution, and hematopoietic chimerism. Blood 1997; 90:4725–4735.

    PubMed  CAS  Google Scholar 

  46. Anasetti C, Beatty PG, Storb R, et al. Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. Hum Immunol 1990; 29:79–91.

    PubMed  CAS  Google Scholar 

  47. Anasetti C, Amos D, Beatty PG, et al. Effect of HLA compatibility on engraft-ment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 1989; 320:197–204.

    PubMed  CAS  Google Scholar 

  48. Gaziev D, Galimberti M, Lucarelli G, et al. Bone marrow transplantation from alternative donors for thalassemia: HLA-phenotypically identical relative and HLA-nonidentical sibling or parent transplants. Bone Marrow Transplant 2000; 25:815–821.

    PubMed  CAS  Google Scholar 

  49. Drobyski WR, Klein J, Flomenberg N, et al. Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly human leukocyte antigen-disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishing a treatment algorithm for recipients of alternative donor grafts. Blood 2002; 99:806–814.

    PubMed  CAS  Google Scholar 

  50. Caillat-Zucman S, Le Deist F, Haddad E, et al. Impact of HLA matching on outcome of hematopoietic stem cell transplantation in children with inherited diseases: a single-center comparative analysis of genoidentical, haploidentical or unrelated donors. Bone Marrow Transplant 2004; 33:1089–1095.

    PubMed  CAS  Google Scholar 

  51. Bunin N, Aplenc R, Leahey A, et al. Outcomes of transplantation with partial T-cell depletion of matched or mismatched unrelated or partially matched related donor bone marrow in children and adolescents with leukemias. Bone Marrow Transplant 2005; 35:151–158.

    PubMed  CAS  Google Scholar 

  52. van Rood JJ, Loberiza FR, Jr., Zhang MJ, et al. Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling. Blood 2002; 99:1572–1577.

    PubMed  Google Scholar 

  53. Tamaki S, Ichinohe T, Matsuo K, et al. Superior survival of blood and marrow stem cell recipients given maternal grafts over recipients given paternal grafts. Bone Marrow Transplant 2001; 28:375–380.

    PubMed  CAS  Google Scholar 

  54. Shimazaki C, Ochiai N, Uchida R, et al. Non-T-cell-depleted HLA haploidentical stem cell transplantation in advanced hematologic malignancies based on the feto-maternal michrochimerism. Blood 2003; 101:3334–3336.

    PubMed  CAS  Google Scholar 

  55. Obama K, Utsunomiya A, Takatsuka Y, Takemoto Y. Reduced-intensity non-T-cell depleted HLA-haploidentical stem cell transplantation for older patients based on the concept of feto-maternal tolerance. Bone Marrow Transplant 2004; 34:897–899.

    PubMed  CAS  Google Scholar 

  56. Shimazaki C, Fuchida S, Ochiai N, et al. Non-T-cell-depleted HLA-haploidentical stem cell transplantation after reduced-intensity conditioning in advanced haema-tological malignancies based on feto-maternal microchimerism. Br J Haematol 2004; 127:474–475.

    PubMed  Google Scholar 

  57. Davies SM, Defor TE, McGlave PB, et al. Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypi-cally matched bone marrow from related or unrelated donors. Am J Med 2001; 110:339–346.

    PubMed  CAS  Google Scholar 

  58. Ottinger HD, Ferencik S, Beelen DW, et al. Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors. Blood 2003; 102:1131–1137.

    PubMed  CAS  Google Scholar 

  59. Saarinen-Pihkala UM, Gustafsson G, Ringden O, et al. No disadvantage in outcome of using matched unrelated donors as compared with matched sibling donors for bone marrow transplantation in children with acute lymphoblastic leukemia in second remission. J Clin Oncol 2001; 19:3406–3414.

    PubMed  CAS  Google Scholar 

  60. Gustafsson A, Remberger M, Winiarski J, Ringden O. Unrelated bone marrow transplantation in children: outcome and a comparison with sibling donor grafting. Bone Marrow Transplant 2000; 25:1059–1065.

    PubMed  CAS  Google Scholar 

  61. Hongeng S, Krance RA, Bowman LC, et al. Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukaemia. Lancet 1997; 350:767–771.

    PubMed  CAS  Google Scholar 

  62. Kiehl MG, Kraut L, Schwerdtfeger R, et al. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission. J Clin Oncol 2004; 22:2816–2825.

    PubMed  Google Scholar 

  63. Ho VT, Kim HT, Liney D, et al. HLA-C mismatch is associated with inferior survival after unrelated donor non-myeloablative hematopoietic stem cell transplantation. Bone Marrow Transplant 2006; 37:845–850.

    PubMed  CAS  Google Scholar 

  64. Hegenbart U, Niederwieser D, Sandmaier BM, et al. Treatment for acute myel-ogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors. J Clin Oncol 2006; 24:444–453.

    PubMed  CAS  Google Scholar 

  65. Ottinger HD, Ferencik S, Beelen DW, et al. Impact of HLA-A,B,C allele mismatches on outcome after unrelated blood stem cell transplantation in whites. Transplantation 2004; 78:1077–1080.

    PubMed  CAS  Google Scholar 

  66. Chalandon Y, Tiercy JM, Schanz U, et al. Impact of high-resolution matching in allogeneic unrelated donor stem cell transplantation in Switzerland. Bone Marrow Transplant 2006; 37:909–916.

    PubMed  CAS  Google Scholar 

  67. Carreras E, Jimenez M, Gomez-Garcia V, et al. Donor age and degree of HLA matching have a major impact on the outcome of unrelated donor haematopoietic cell transplantation for chronic myeloid leukaemia. Bone Marrow Transplant 2006; 37:33–40.

    PubMed  CAS  Google Scholar 

  68. Greinix HT, Fae I, Schneider B, et al. Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors. Bone Marrow Transplant 2005; 35:57–62.

    PubMed  CAS  Google Scholar 

  69. Varney MD, Lester S, McCluskey J, Gao X, Tait BD. Matching for HLA DPA1 and DPB1 alleles in unrelated bone marrow transplantation. Hum Immunol 1999; 60:532–538.

    PubMed  CAS  Google Scholar 

  70. Petersdorf EW, Gooley T, Malkki M, et al. The biological significance of HLA-DP gene variation in haematopoietic cell transplantation. Br J Haematol 2001; 112:988–994.

    PubMed  CAS  Google Scholar 

  71. Loiseau P, Esperou H, Busson M, et al. DPB1 disparities contribute to severe GVHD and reduced patient survival after unrelated donor bone marrow transplantation. Bone Marrow Transplant 2002; 30:497–502.

    PubMed  CAS  Google Scholar 

  72. Shaw BE, Marsh SG, Mayor NP, Russell NH, Madrigal JA. HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants. Blood 2006; 107:1220–1226.

    PubMed  CAS  Google Scholar 

  73. Fleischhauer K, Locatelli F, Zecca M, et al. Graft rejection after unrelated donor hemat-opoietic stem cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus-graft direction. Blood 2006; 107:2984–2992.

    PubMed  CAS  Google Scholar 

  74. Lee SJ, Klein J, Haagenson M, et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007; 110:4576–83.

    PubMed  CAS  Google Scholar 

  75. Ferrara GB, Bacigalupo A, Lamparelli T, et al. Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain. Blood 2001; 98:3150–3155.

    PubMed  CAS  Google Scholar 

  76. Heemskerk MB, Roelen DL, Dankers MK, et al. Allogeneic MHC class I molecules with numerous sequence differences do not elicit a CTL response. Hum Immunol 2005; 66:969–976.

    PubMed  CAS  Google Scholar 

  77. Petersdorf EW, Gooley T, Malkki M, Horowitz M. Clinical significance of donor-recipient HLA matching on survival after myeloablative hematopoietic cell transplantation from unrelated donors. Joint report of the IHWG in HCT. Proceedings of the 14th International Histocompatibility Workshop and Conference. Tissue Antigens. 69 (Suppl 1):25–30, 2007.

    PubMed  Google Scholar 

  78. Morishima Y, Takakazu K, Malkki M, Petersdorf EW. Effect of HLA-A2 allele disparity on clinical outcome in hematopoietic cell transplantation from unrelated donors. Joint report of the IHWG in HCT. Proceedings of the 14th international Histocompatibility Workshop and Conference. Tissue Antigens. 69 (Suppl 1):31–5, 2007.

    PubMed  Google Scholar 

  79. Atsuta Y, Suzuki R, Yamamoto K, et al. Risk and prognostic factors for Japanese patients with chronic graft-versus-host disease after bone marrow transplantation. Bone Marrow Transplant 2006; 37:289–296.

    PubMed  CAS  Google Scholar 

  80. Mathe G, Amiel JL, Schwarzenberg L, et al. Successful allogeneic bone marrow transplantation in man: chimerism, induced specific tolerance and possible anti-leukemia effects. Blood 1965; 25:179–196.

    PubMed  CAS  Google Scholar 

  81. Cook MA, Milligan DW, Fegan CD, et al. The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia. Blood 2004; 103:1521–1526.

    PubMed  CAS  Google Scholar 

  82. Passweg JR, Stern M, Koehl U, Uharek L, Tichelli A. Use of natural killer cells in hematopoetic stem cell transplantation (Review). Bone Marrow Transplant 2005; 35:637–643.

    PubMed  CAS  Google Scholar 

  83. Beelen DW, Ottinger HD, Ferencik S, et al. Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias. Blood 2005; 105:2594–2600.

    PubMed  CAS  Google Scholar 

  84. Giebel S, Locatelli F, Lamparelli T, et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood 2003; 102:814–819.

    PubMed  CAS  Google Scholar 

  85. Bornhauser M, Schwerdtfeger R, Martin H, Frank KH, Theuser C, Ehninger G. Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors. Blood 2004; 103:2860–2861.

    PubMed  Google Scholar 

  86. Davies SM, Ruggieri L, DeFor T, et al. Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobu-lin-like receptor. Blood 2002; 100:3825–3827.

    PubMed  CAS  Google Scholar 

  87. Schaffer M, Malmberg KJ, Ringden O, Ljunggren HG, Remberger M. Increased infection-related mortality in KIR-ligand-mismatched unrelated allogeneic hemat-opoietic stem-cell transplantation. Transplantation 2004; 78:1081–1085.

    PubMed  Google Scholar 

  88. Farag SS, Bacigalupo A, Eapen M, et al. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the Center for International Blood and Marrow Transplant Research, the European Blood and Marrow Transplant Registry, and the Dutch Registry. Biol Blood Marrow Transplant 2006; 12:876–884.

    PubMed  CAS  Google Scholar 

  89. Hsu KC, Gooley T, Malkki M, et al. KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy. Biol Blood Marrow Transplant 2006; 12:828–836.

    PubMed  CAS  Google Scholar 

  90. Sun J Y, Gaidulis L, Dagis A, et al. Killer Ig-like receptor (KIR) compatibility plays a role in the prevalence of acute GVHD in unrelated hematopoietic cell transplants for AML. Bone Marrow Transplant 2005; 36:525–530.

    PubMed  Google Scholar 

  91. Hsu KC, Keever-Taylor CA, Wilton A, et al. Improved outcome in HLA-identical sibling hematopoietic stem cell transplantation for acute myelogenous leukemia (AML) predicted by KIR and HLA genotypes. Blood 2005; 105:4878–4884.

    PubMed  CAS  Google Scholar 

  92. Leung W, Iyengar R, Turner V, et al. Determinants of antileukemia effects of allogeneic NK cells. J Immunol 2004; 172:644–650.

    PubMed  CAS  Google Scholar 

  93. Gagne K, Brizard G, Gueglio B, et al. Relevance of KIR gene polymorphisms in bone marrow transplantation outcome. Hum Immunol 2002; 63:271–280.

    PubMed  CAS  Google Scholar 

  94. Gourraud PA, Mano S, Barnetche T, Carrington M, Inoko H, Cambon-Thomsen A. Integration of microsatellite characteristics in the MHC region: a literature and sequence based analysis. Tissue Antigens 2004; 64:543–555.

    PubMed  CAS  Google Scholar 

  95. Cullen M, Malasky M, Harding A, Carrington M. High-density map of short tandem repeats across the human major histocompatibility complex. Immunogenetics 2003; 54:900–910.

    PubMed  CAS  Google Scholar 

  96. Malkki M, Single R, Carrington M, Thomson G, Petersdorf E. MHC microsatellite diversity and linkage disequilibrium among common HLA-A, HLA-B, DRB1 haplotypes: implications for unrelated donor hematopoietic transplantation and disease association studies. Tissue Antigens 2005; 66:124.

    Google Scholar 

  97. Li S, Kawata H, Katsuyama Y, et al. Association of polymorphic MHC microsatellites with GVHD, survival, and leukemia relapse in unrelated hematopoietic stem cell transplant donor/recipient pairs matched at five HLA loci. Tissue Antigens 2004; 63:362–368.

    PubMed  CAS  Google Scholar 

  98. Foissac A, Fort M, Clayton J, et al. Microsatellites in the HLA region: HLA prediction and strategies for bone marrow donor registries. Transplant Proc 2001; 33:491–492.

    PubMed  CAS  Google Scholar 

  99. Gourraud PA, Lamiraux P, El Kadhi N, Raffoux C, Cambon-Thomsen A. Inferred HLA haplotype information for donors from hematopoietic stem cells donor registries. Hum Immunol 2005; 66:563–570.

    PubMed  CAS  Google Scholar 

  100. Carrington M, Wade J. Selection of transplant donors based on MHC microsatel-lite data. Hum Immunol 1996; 50:151–154.

    PubMed  CAS  Google Scholar 

  101. Malkki M, Gooley T, Horowitz M, Petersdorf EW. MHC class I, III, II microsatel-lite marker matching and survival in unrelated donor hematopoietic cell transplantation. Tissue Antigens. 69 (Suppl 1):46–9, 2007.

    Google Scholar 

  102. Ahmad T, Neville M, Marshall SE, et al. Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC. Hum Mol Genet 2003; 12:647–656.

    PubMed  CAS  Google Scholar 

  103. Stewart CA, Horton R, Allcock RJ, et al. Complete MHC haplotype sequencing for common disease gene mapping. Genome Res 2004; 14:1176–1187.

    PubMed  CAS  Google Scholar 

  104. Miretti MM, Walsh EC, Ke X, et al. A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms. Am J Hum Genet 2005; 76:634–646.

    PubMed  CAS  Google Scholar 

  105. Traherne JA, Horton R, Roberts AN, et al. Genetic analysis of completely sequenced disease-associated MHC haplotypes identifies shuffling of segments in recent human history. PLoS Genetics 2006; 2:e9.

    PubMed  Google Scholar 

  106. de Bakker PI, McVean G, Sabeti PC, et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet 2006; 38:1166–1172.

    PubMed  CAS  Google Scholar 

  107. Walsh EC, Mather KA, Schaffner SF, et al. An integrated haplotype map of the human major histocompatibility complex. Am J Hum Genet 2003; 73:580–590.

    PubMed  CAS  Google Scholar 

  108. Ketheesan N, Gaudieri S, Witt CS, et al. Reconstruction of the block matching profiles. Hum Immunol 1999; 60:171–176.

    PubMed  CAS  Google Scholar 

  109. Tay GK, Witt CS, Christiansen FT, et al. Matching for MHC haplotypes results in improved survival following unrelated bone marrow transplantation. Bone Marrow Transplant 1995; 15:381–385.

    PubMed  CAS  Google Scholar 

  110. Fallin D, Schork NJ. Accuracy of haplotype frequency estimation for biallelic loci, via the expectation-maximization algorithm for unphased diploid genotype data. Am J Hum Genet 2000; 67:947–959.

    PubMed  CAS  Google Scholar 

  111. Tishkoff SA, Pakstis AJ, Ruano G, Kidd KK. The accuracy of statistical methods for estimation of haplotype frequencies: an example from the CD4 locus. Am J Hum Genet 2000; 67:518–522.

    PubMed  CAS  Google Scholar 

  112. Guo Z, Hood L, Malkki M, Petersdorf EW. Long-range multilocus haplotype phasing of the MHC [erratum appears in Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9374]. PNAS 2006; 103:6964–6969.

    PubMed  CAS  Google Scholar 

  113. Petersdorf EW, Malkki M, Gooley TA, Martin PJ, Guo Z. MHC haplotype matching for unrelated hematopoietic cell transplantation. PLoS Medicine. 4(1):e8, 2007.

    PubMed  Google Scholar 

Download references

Acknowledgments

Effie Petersdorf is supported by grants CA18029, CA100019, AI33484 and AI069197 from the National Institutes of Health.

Author information

Authors and Affiliations

  1. Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA

    Effie W. Petersdorf

Authors
  1. Effie W. Petersdorf
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Hematologic Malignancies, Dana-Farber Cancer Institute, 44 Binney Street, DFCI D1B30, Boston, MA, 02115, USA

    Robert J. Soiffer MD

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Petersdorf, E.W. (2008). Stem Cell Transplantation for Hematologic Malignancies. In: Soiffer, R.J. (eds) Hematopoietic Stem Cell Transplantation. Contemporary Hematology. Humana Press. https://doi.org/10.1007/978-1-59745-438-4_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-438-4_2

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-934115-05-3

  • Online ISBN: 978-1-59745-438-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation